In Treatment of Type 2 diabetes mellitus Voglip 0.3mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Voglip 0.3mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
It is unsafe to consume alcohol with Voglip 0.3mg Tablet.
Voglip 0.3mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Voglip 0.3mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Voglip 0.3mg Tablet does not usually affect your ability to drive.
Voglip 0.3mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Voglip 0.3mg Tablet may be needed. Please consult your doctor.
There is limited information available on the use of Voglip 0.3mg Tablet in patients with liver disease. Please consult your doctor.
If you miss a dose of Voglip 0.3mg Tablet, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Tycoon Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Wallace Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Foncer Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Allysia Lifesciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Clover Health Care Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Orchid Chemicals & Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Intra Life || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ind Swift Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Maxx Farmacia (India) Lip || ₹14.5/tablet (25% cheaper)